IQVIA Holdings EBITDA 2012-2025 | IQV
IQVIA Holdings annual and quarterly EBITDA history from 2012 to 2025. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
- IQVIA Holdings EBITDA for the quarter ending September 30, 2025 was $845M, a 1.44% increase year-over-year.
- IQVIA Holdings EBITDA for the twelve months ending September 30, 2025 was $3.333B, a 3.35% increase year-over-year.
- IQVIA Holdings 2024 annual EBITDA was $3.337B, a 6.96% increase from 2023.
- IQVIA Holdings 2023 annual EBITDA was $3.12B, a 5.98% increase from 2022.
- IQVIA Holdings 2022 annual EBITDA was $2.944B, a 10.1% increase from 2021.
|
IQVIA Holdings Annual EBITDA (Millions of US $) |
|
|---|---|
| 2024 | $3,337 |
| 2023 | $3,120 |
| 2022 | $2,944 |
| 2021 | $2,674 |
| 2020 | $2,036 |
| 2019 | $1,992 |
| 2018 | $1,893 |
| 2017 | $1,728 |
| 2016 | $926 |
| 2015 | $793 |
| 2014 | $718 |
| 2013 | $592 |
| 2012 | $504 |
| 2011 | $467 |
|
IQVIA Holdings Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2025-09-30 | $845 |
| 2025-06-30 | $788 |
| 2025-03-31 | $766 |
| 2024-12-31 | $934 |
| 2024-09-30 | $833 |
| 2024-06-30 | $795 |
| 2024-03-31 | $775 |
| 2023-12-31 | $822 |
| 2023-09-30 | $783 |
| 2023-06-30 | $787 |
| 2023-03-31 | $728 |
| 2022-12-31 | $740 |
| 2022-09-30 | $724 |
| 2022-06-30 | $726 |
| 2022-03-31 | $754 |
| 2021-12-31 | $728 |
| 2021-09-30 | $642 |
| 2021-06-30 | $634 |
| 2021-03-31 | $670 |
| 2020-12-31 | $638 |
| 2020-09-30 | $511 |
| 2020-06-30 | $375 |
| 2020-03-31 | $512 |
| 2019-12-31 | $483 |
| 2019-09-30 | $507 |
| 2019-06-30 | $494 |
| 2019-03-31 | $508 |
| 2018-12-31 | $504 |
| 2018-09-30 | $467 |
| 2018-06-30 | $454 |
| 2018-03-31 | $468 |
| 2017-12-31 | $423 |
| 2017-09-30 | $453 |
| 2017-06-30 | $413 |
| 2017-03-31 | $439 |
| 2016-12-31 | $295 |
| 2016-09-30 | $232 |
| 2016-06-30 | $183 |
| 2016-03-31 | $216 |
| 2015-12-31 | $219 |
| 2015-09-30 | $205 |
| 2015-06-30 | $194 |
| 2015-03-31 | $175 |
| 2014-12-31 | $193 |
| 2014-09-30 | $181 |
| 2014-06-30 | $172 |
| 2014-03-31 | $172 |
| 2013-12-31 | $162 |
| 2013-09-30 | $154 |
| 2013-06-30 | $132 |
| 2013-03-31 | $143 |
| 2012-12-31 | $124 |
| 2012-09-30 | $137 |
| 2012-06-30 | $127 |
| 2012-03-31 | $117 |
| 2011-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $41.139B | $15.405B |
| IQVIA Holdings Inc. provides advanced analytics, technology solutions and contract research services to the life sciences industry. The company was formed through the merger of IMS Health (RX) and Quintiles. The company is focused on helping healthcare clients to better serve patients by bringing in updated and innovative ideas in the process of clinical development and commercialization, speed innovation and accelerate improvements. I | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $228.085B | 27.10 |
| Intuitive Surgical (ISRG) | United States | $201.399B | 78.80 |
| IDEXX Laboratories (IDXX) | United States | $57.017B | 56.62 |
| Edwards Lifesciences (EW) | United States | $48.652B | 32.62 |
| Alcon (ALC) | Switzerland | $38.961B | 26.33 |
| Mettler-Toledo (MTD) | United States | $30.332B | 35.49 |
| DexCom (DXCM) | United States | $27.399B | 37.77 |
| STERIS (STE) | Ireland | $25.505B | 26.33 |
| Waters (WAT) | United States | $23.464B | 31.03 |
| Coloplast (CLPBY) | Denmark | $20.125B | 34.35 |
| Hologic (HOLX) | United States | $16.689B | 17.53 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.475B | 0.00 |
| Globus Medical (GMED) | United States | $12.067B | 25.33 |
| Penumbra (PEN) | United States | $11.787B | 82.91 |
| Masimo (MASI) | United States | $6.974B | 22.35 |
| Glaukos (GKOS) | United States | $6.331B | 0.00 |
| Sysmex ADR (SSMXY) | Japan | $6.289B | 19.98 |
| TransMedics (TMDX) | United States | $4.877B | 57.78 |
| Teleflex (TFX) | United States | $4.592B | 7.32 |
| Veracyte (VCYT) | United States | $3.403B | 38.78 |
| LivaNova (LIVN) | United Kingdom | $3.349B | 18.09 |
| Integer Holdings (ITGR) | United States | $2.899B | 13.61 |
| Alphatec Holdings (ATEC) | United States | $2.444B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.366B | 22.14 |
| Nihon Kohden (NHNKY) | Japan | $2.034B | 17.76 |
| Artivion (AORT) | United States | $2.032B | 93.26 |
| UFP Technologies (UFPT) | United States | $1.947B | 25.71 |
| PROCEPT BioRobotics (PRCT) | United States | $1.709B | 0.00 |
| AxoGen (AXGN) | United States | $1.427B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.417B | 0.00 |
| IRadimed (IRMD) | United States | $1.263B | 60.15 |
| OPKO Health (OPK) | United States | $1.029B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.961B | 5.21 |
| Pulse Biosciences (PLSE) | United States | $0.959B | 0.00 |
| SiBone (SIBN) | United States | $0.776B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.760B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.669B | 38.90 |
| Pacific Biosciences Of California (PACB) | United States | $0.643B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.586B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.556B | 0.00 |
| NeuroPace (NPCE) | United States | $0.537B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.529B | 10.56 |
| OrthoPediatrics (KIDS) | United States | $0.469B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.466B | 12.86 |
| RxSight (RXST) | United States | $0.416B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.415B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.411B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.368B | 61.29 |
| Sight Sciences (SGHT) | United States | $0.361B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.32 |
| Spectral Diagnostics (EDTXF) | Canada | $0.310B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.199B | 0.00 |
| 908 Devices (MASS) | United States | $0.194B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.185B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.173B | 0.00 |
| Inogen (INGN) | United States | $0.169B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.164B | 0.00 |
| CVRx (CVRX) | United States | $0.160B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.153B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.151B | 0.00 |
| Solana (HSDT) | United States | $0.142B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.142B | 0.00 |
| LENSAR (LNSR) | United States | $0.140B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.135B | 0.00 |
| Neuronetics (STIM) | United States | $0.123B | 0.00 |
| Hyperfine (HYPR) | United States | $0.111B | 0.00 |
| Accuray (ARAY) | United States | $0.098B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.087B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.082B | 0.00 |
| DarioHealth (DRIO) | United States | $0.079B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.068B | 0.00 |
| InspireMD (NSPR) | United States | $0.067B | 0.00 |
| Positron (POSC) | United States | $0.057B | 0.00 |
| Spectral AI (MDAI) | United States | $0.049B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.034B | 0.00 | |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.022B | 0.00 |
| Envoy Medical (COCH) | United States | $0.020B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.018B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.014B | 0.00 |
| NexGel (NXGL) | United States | $0.014B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.014B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.012B | 0.00 |
| Tenon Medical (TNON) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.008B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.007B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| ENvue Medical (FEED) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 11.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |